When the University of Minnesota announced in July that Kate Adamala’s laboratory had built a synthetic cell nicknamed SpudCell, the story travelled fast and the framing was bold. New Scientist called it arguably the greatest bioengineering feat yet, while noting in the same piece that the cell needs a lot of outside help just to divide badly and fails after roughly five division cycles. The lab’s own project page, published through the newly founded research group Biotic, describes SpudCell as the first system built entirely bottom-up from purified, non-living components to complete a full cell cycle, according to biotic.org.
The manuscript behind the announcement tells a narrower story than the headlines suggested. It was posted to bioRxiv the day after the public unveiling and has not yet completed peer review, according to Science News. That outlet reported that only about 30 percent of SpudCells inherited a complete seven-piece genome after five generations, because the system lacks a cytoskeleton to guide even division. Adamala herself told Science News that the cells are obviously not living, describing them as cells but not alive, and said she would be satisfied calling the system living only if it could replicate indefinitely and undergo genuine Darwinian evolution rather than deliberately introduced mutation.
What the exaggeration research actually measures
The gap between announcement and preprint fits a pattern that researchers of science communication have documented for years. A public commentary from the independent newsletter thebiologyreboot laid out the sequence in detail, reporting that the manuscript had been rejected by the journal Cell after a reviewer objected that it was not real biology, and that Adamala’s team then sent the manuscript to journalists under embargo before uploading it to bioRxiv for other scientists to read, according to thebiologyreboot.substack.com. That commentary quoted a public bioRxiv comment from postdoctoral researcher Max Haase arguing that the surrounding framing implied a degree of self-sustaining, cell-like behaviour that the experiments had not yet shown.
That order of events, publicity first and peer scrutiny after, is the pattern that critics of institutional science communication have flagged repeatedly as a driver of overstatement in news coverage. The SpudCell case did not lack caveats altogether. New Scientist reported plainly that the system needs a lot of outside help and fails after about five divisions, and Science News reported the 30 percent inheritance figure directly from the preprint. But those caveats generally sat well below the initial framing that treated SpudCell as a step toward built-to-order life.
How the outlets framed it
New Scientist framed SpudCell as arguably the greatest bioengineering feat to date, folding its major limitations into the same piece but keeping the headline framing celebratory. Science News took the opposite structural approach, leading with a direct rebuttal that the first synthetic life is not alive, then walking through the 30 percent genome inheritance figure and Adamala’s own admission that the cells are not living. The independent newsletter thebiologyreboot went further still, arguing that the sequence of embargoed press access followed by an unreviewed bioRxiv posting shifted the authority to judge scientific validity away from peer reviewers and toward publicity managed by the university and the researchers themselves. The difference reveals two competing assumptions about where responsibility for accuracy sits: mainstream coverage treated the researchers’ own claims as a reasonable starting point to be qualified later in the story, while the independent critique treated the publicity strategy itself as the central story worth scrutinising.
Who benefits from the gap
University communications offices and the newly formed Biotic research institution, which Stanford synthetic biologist Drew Endy helped found alongside Adamala with roughly ten million dollars in seed funding according to reporting cited by outside commentators, have an evident interest in generating attention that can be cited toward future grants and donor support. A release describing a single unreviewed study as a milestone toward built life is more useful for that purpose than one describing it as a preliminary result awaiting replication and peer review. Neither the university’s communications office nor the researchers have addressed, in anything reviewed for this article, whether the incentive to publicise ahead of peer review can be corrected through better drafting alone or whether it is built into how modern research institutions compete for attention and funding.
